Description of Parkinson's Disease as a Clinical Syndrome
Top Cited Papers
- 1 June 2003
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 991 (1) , 1-14
- https://doi.org/10.1111/j.1749-6632.2003.tb07458.x
Abstract
Abstract: Parkinsonism is a clinical syndrome comprising combinations of motor problems—namely, bradykinesia, resting tremor, rigidity, flexed posture, “freezing,” and loss of postural reflexes. Parkinson's disease (PD) is the major cause of parkinsonism. PD is a slowly progressive parkinsonian syndrome that begins insidiously and usually affects one side of the body before spreading to involve the other side. Pathology shows loss of neuromelanin‐containing monoamine neurons, particularly dopamine (DA) neurons in the substantia nigra pars compacta. A pathologic hallmark is the presence of cytoplasmic eosinophilic inclusions (Lewy bodies) in monoamine neurons. The loss of DA content in the nigrostriatal neurons accounts for many of the motor symptoms, which can be ameliorated by DA replacement therapy—that is, levodopa. Most cases are sporadic, of unknown etiology; but rare cases of monogenic mutations (10 genes at present count) show that there are multiple causes for the neuronal degeneration. The pathogenesis of PD remains unknown. Clinical fluctuations and dyskinesias are frequent complications of levodopa therapy; these, as well as some motor features of PD, improve by resetting the abnormal brain physiology towards normal by surgical therapy. Nonmotor symptoms (depression, lack of motivation, passivity, and dementia) are common. As the disease progresses, even motor symptoms become intractable to therapy. No proven means of slowing progression have yet been found.Keywords
This publication has 22 references indexed in Scilit:
- Survival Study of Parkinson Disease in Olmsted County, MinnesotaArchives of Neurology, 2003
- Risk tables for parkinsonism and Parkinson's diseaseJournal of Clinical Epidemiology, 2002
- Parkinson Disease in TwinsAn Etiologic StudyJAMA, 1999
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973
- Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen SystemsJournal of Molecular Medicine, 1960
- Distribution of catechol compounds in human brainBiochimica et Biophysica Acta, 1959
- Akinesia in Parkinson's diseaseNeurology, 1959
- On the Presence of 3-Hydroxytyramine in BrainScience, 1958
- 3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine AntagonistsNature, 1957
- THE BRAIN-STEM LESIONS IN PARKINSONISMJournal of Neurology, Neurosurgery & Psychiatry, 1953